Northland raised the firm’s price target on Viavi (VIAV) to $19 from $17 and keeps an Outperform rating on the shares following a fiscal Q1 report and outlook that showed upside. With the company noting the potential for $1.00 per share in FY27 EPS, the firm sees “significant upside potential in the shares,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
